Novacyt (PA:ALNOV) — Stock Price
Novacyt (PA:ALNOV) is currently trading at €0.46 EUR, up 4.55% today. Over the past 52 weeks, shares have ranged between €0.32 and €0.90. This page tracks Novacyt's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Novacyt.
Novacyt (ALNOV) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Novacyt's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Novacyt Income Statement — Revenue, Profit & Earnings by Year
Novacyt's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €20.40 Million | €19.63 Million | €11.58 Million | €21.04 Million | €95.78 Million |
| Cost of Revenue | €12.52 Million | €-12.44 Million | €7.85 Million | €15.29 Million | €66.10 Million |
| Gross Profit | €7.89 Million | €32.07 Million | €3.73 Million | €5.75 Million | €29.68 Million |
| Research & Development | €4.19 Million | €2.77 Million | €3.23 Million | €5.05 Million | €4.82 Million |
| SG&A | — | €40.24 Million | €4.88 Million | €4.86 Million | €6.81 Million |
| Total Operating Expenses | €21.06 Million | €69.42 Million | €33.25 Million | €22.35 Million | €31.05 Million |
| Operating Income | €-13.18 Million | €-37.34 Million | €-29.52 Million | €-16.60 Million | €-1.37 Million |
| EBITDA | €-8.21 Million | €-34.31 Million | €-18.24 Million | €-11.68 Million | €-4.20 Million |
| EBIT | €-13.18 Million | €-34.11 Million | €-27.89 Million | €-14.16 Million | €-6.28 Million |
| Interest Expense | €679.48K | €5.12 Million | €682.00K | €489.00K | €239.00K |
| Income Before Tax | €-27.86 Million | €-39.43 Million | €-28.57 Million | €-20.05 Million | €-9.83 Million |
| Income Tax Expense | €-3.97 Million | €-732.00K | €-768.00K | €2.15 Million | €-101.00K |
| Net Income | €-23.31 Million | €-41.76 Million | €-28.29 Million | €-22.20 Million | €-9.73 Million |
Novacyt Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Novacyt's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €40.28 Million | €70.63 Million | €133.81 Million | €140.90 Million | €183.70 Million |
| Total Current Assets | €27.67 Million | €39.38 Million | €86.45 Million | €127.24 Million | €158.78 Million |
| Cash & Equivalents | — | €30.45 Million | — | €86.97 Million | €101.75 Million |
| Short-term Investments | €9.99K | €8.00K | €9.00K | €9.00K | €9.00K |
| Net Receivables | €5.01 Million | €3.71 Million | €27.49 Million | €38.00 Million | €35.87 Million |
| Inventory | €2.53 Million | €2.27 Million | €3.02 Million | €3.03 Million | €11.46 Million |
| Property, Plant & Equipment | — | €10.70 Million | €15.22 Million | €3.27 Million | €6.38 Million |
| Goodwill | €2.16 Million | €2.67 Million | €21.45 Million | €6.65 Million | €11.47 Million |
| Total Liabilities | €16.94 Million | €22.75 Million | €46.57 Million | €25.68 Million | €41.88 Million |
| Total Current Liabilities | €5.83 Million | €6.22 Million | €29.57 Million | €24.24 Million | €38.90 Million |
| Long-term Debt | — | €0.00 | €722.00K | — | €0.00 |
| Net Debt | €-8.69 Million | €-18.57 Million | €-30.35 Million | €-86.10 Million | €-99.88 Million |
| Total Stockholder Equity | €23.34 Million | €47.88 Million | €87.24 Million | €115.22 Million | €141.81 Million |
| Retained Earnings | €-52.89 Million | €-11.70 Million | €29.90 Million | €61.45 Million | €87.19 Million |
Novacyt Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Novacyt generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-8.76 Million | €-9.82 Million | €-24.99 Million | €-13.73 Million | €15.69 Million |
| Capital Expenditures | €273.01K | €1.86 Million | €671.00K | €416.00K | €4.10 Million |
| Free Cash Flow | €-9.03 Million | €-11.01 Million | €-25.66 Million | €-14.14 Million | €11.59 Million |
| Investing Cash Flow | €-811.91K | €-1.88 Million | €-13.94 Million | €-577.00K | €-5.03 Million |
| Financing Cash Flow | €-1.99 Million | €-1.84 Million | €-3.97 Million | €-516.00K | €-599.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | €19.19K | — |
| Depreciation | €4.96 Million | €-202.00K | €9.64 Million | €7.92 Million | €7.88 Million |
| Change in Cash | €-13.00 Million | €-13.60 Million | €-42.92 Million | €-14.77 Million | €9.98 Million |
Novacyt Earnings History — EPS Actual vs. Analyst Estimates
Track Novacyt's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 03, 2025 | 0.00 | 0.00 | — |
| Sep 30, 2025 | 0.00 | 0.00 | — |
| Apr 30, 2025 | 0.00 | 0.00 | — |
| Nov 27, 2024 | 0.00 | 0.00 | — |
| Sep 26, 2024 | -0.25 | 0.00 | — |
| May 29, 2024 | 0.00 | 0.00 | — |
| Nov 29, 2023 | 0.00 | 0.00 | — |
| Sep 28, 2023 | 0.00 | 0.00 | — |